158 related articles for article (PubMed ID: 37539572)
1. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of hepatic pathological inflammation and fibrosis condition and its influencing factors in 721 patients with chronic hepatitis B with normal ALT].
Ning HB; Jin HM; Li K; Peng Z; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):746-751. PubMed ID: 36038345
[No Abstract] [Full Text] [Related]
3. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
Gao Y; Wang M; Liu X
Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
[TBL] [Abstract][Full Text] [Related]
4. Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.
Wei S; Xie Q; Liao G; Chen H; Hu M; Lin X; Li H; Peng J
BMC Gastroenterol; 2024 Mar; 24(1):120. PubMed ID: 38532310
[TBL] [Abstract][Full Text] [Related]
5. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
[TBL] [Abstract][Full Text] [Related]
6. Total serum bile acids predict therapy for HBeAg-negative chronic hepatitis B patients with borderline ALT and high HBV DNA.
Xie R; Li J; Zhang H; Wang LM; Huang CR; Chen LW
J Infect Dev Ctries; 2022 Aug; 16(8):1336-1342. PubMed ID: 36099378
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic pathological characteristics and factors influencing alanine transaminase value below twice the upper limit of normal in patients with chronic hepatitis B].
Wang XH; Liu XQ; Cai DC; Hu P; Li H
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):483-488. PubMed ID: 37365024
[No Abstract] [Full Text] [Related]
8. Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone.
Ren S; Wang W; Lu J; Wang K; Ma L; Zheng Y; Zheng S; Chen X
Front Immunol; 2022; 13():1035923. PubMed ID: 36389814
[TBL] [Abstract][Full Text] [Related]
9. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
10. Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels.
Yan JY; Li ZQ; Yu ZJ; Kan QC
J Cell Biochem; 2019 Apr; 120(4):6632-6641. PubMed ID: 30368885
[TBL] [Abstract][Full Text] [Related]
11. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
12. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
[TBL] [Abstract][Full Text] [Related]
13. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
Duan M; Chi X; Xiao H; Liu X; Zhuang H
Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
[TBL] [Abstract][Full Text] [Related]
14. [Demographic characteristics and associated influencing factors in treated patients with chronic hepatitis B with hypoviremia : a single-center retrospective cross-sectional study].
Li T; Kong Y; Liu YY; Liu TF; Ma AD; Li LQ; Pei ZY; Zhang LY
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):42-48. PubMed ID: 36948848
[No Abstract] [Full Text] [Related]
15. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
[TBL] [Abstract][Full Text] [Related]
16. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
17. [Correlation analysis between ICG-R15 and modified Scheuer score in liver tissues of patients with hepatitis B e antigen-positive/negative chronic hepatitis B].
Zhang MM; Zhang SW; Hu X; Bao FY; Pei ZY; Liu YY; Ma AD; Zhang LY
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):565-570. PubMed ID: 34225432
[No Abstract] [Full Text] [Related]
18. Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection.
Wu S; Du X; Lou G; Yu S; Lai K; Qi J; Ni S; Chen Z; Chen F
BMC Infect Dis; 2022 Nov; 22(1):842. PubMed ID: 36368952
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity].
Gao Y; Zou G; Ye J; Pan G; Rao J; Li F; Wei Y; Li X
Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):254-7. PubMed ID: 26133815
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study.
Wei S; Hu M; Chen H; Xie Q; Wang P; Li H; Peng J
BMC Gastroenterol; 2022 Aug; 22(1):387. PubMed ID: 35978283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
